Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Merit Medical Systems ( (MMSI) ) has shared an announcement.
On October 30, 2025, Merit Medical Systems announced its financial results for the third quarter of 2025, reporting a revenue of $384.2 million, a 13% increase from the same period in 2024. The company exceeded its financial expectations, prompting an update in its full-year guidance, reflecting confidence in continued growth and profitability.
The most recent analyst rating on (MMSI) stock is a Buy with a $104.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
Merit Medical Systems demonstrates strong financial performance and positive earnings call sentiment, which are the most significant factors driving the score. Technical analysis suggests a neutral trend, while valuation concerns due to a high P/E ratio and no dividend yield slightly offset the positives. The company’s strategic initiatives and leadership changes support a positive outlook despite some market challenges.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc. is a leading global manufacturer and marketer of healthcare technology, specializing in cardiovascular and endoscopy devices. The company focuses on providing innovative medical solutions and is listed on NASDAQ under the ticker MMSI.
Average Trading Volume: 583,551
Technical Sentiment Signal: Hold
Current Market Cap: $4.82B
For an in-depth examination of MMSI stock, go to TipRanks’ Overview page.